News –

 

2014

2013

2012

  • Terapio selected as a participant in the National Institutes of Health’s Accelerated Commercialization Track Program.
  • RLIP76-PL Shows Promise as an Effective Treatment for Nitrogen Mustard Exposure.
  • Terapio awarded grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases.
  • Terapio’s RLIP76 protein technology formally invited to participate in the National Institutes of Health’s Nuclear Countermeasures Product Development Program.

2011

  • Terapio signs Sponsored Research Agreement with The University of Texas at Austin.
  • Dr. Sanjay Awasthi accepts appointment at the City of Hope.
  • Terapio signs Research Collaboration Agreement with the laboratory of Dr. Andrew Ellington at The University of Texas at Austin.

2010

  • Terapio signs Patent License Agreement with the University of North Texas Health Science Center for exclusive, worldwide rights to intellectual property associated with the RLIP76 protein technology.
  • Terapio signs Research Collaboration Agreement with the University of North Texas Health Science Center.
  • Terapio becomes a member of the NASA Human Health and Performance Center.
  • Terapio signs Research Collaboration Agreement with Texas A&M University System Health Science Center.

2009

2008

Terapio

/Tĕ•rah•pē•ō/

means therapy in Esperanto, an international, constructed language introduced by Dr. L.L. Zamenhof in 1887.